• Events
    • OIS@ASRS 2018
    • OIS@AAO 2018
    • Past Events
    • Hall of Fame
    • Advisory Board
  • News
  • OIS Index
  • Videos
  • Podcast
  • Get Involved
    • Sponsorship Opportunities
    • Presenting Companies
    • Companies to Watch
    • Media & Press
    • Advertise With OIS
    • Be Our Podcast Guest
  • Register

Keyword: Regulation

OIS Overview: Haimovitch, Lachman Share Insights On OIS, MIGs, IOLs, etc

OIS Overview: Haimovitch, Lachman Share Insights On OIS, MIGs, IOLs, etc

Veteran Ophthalmology Scribes Larry Haimovitch of Haimovitch Medical Technology Consultants and Mike Lachman of EyeQ Research put down the pens and pick up the Mics to share their insights on ophthalmology. ...

Listen

May 19, 2015 By Tom Salemi

Lifitegrast Heads Up Promising Dry Eye Pipeline

Lifitegrast Heads Up Promising Dry Eye Pipeline

For more than a decade, there has only been one approved pharmacologic treatment for dry eye—Allergan’s Restasis (topical cyclosporine 0.05%). This in a market estimated to be worth more than $2.4 billion, one that ...

Read More

April 8, 2015 By Tom Salemi

Alphaeon’s Grant Explains Innovative New Model

Alphaeon’s Grant Explains Innovative New Model

Alphaeon is tapping physicians for unprecedented involvement in finding and funding new treatments. Hear how the company sees the future of health care. ...

Listen

April 7, 2015 By Tom Salemi

How to Do M&A Well

How to Do M&A Well

Highlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in ...

Play Video

December 3, 2014

IOPtima

IOPtima

Ronen Castro, CEO of Israeli company IOPtima Ltd., introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but is non-invasive. This was the ...

Play Video

November 25, 2014

Alcon’s Head Jeff George Lays Out Vision

Alcon’s Head Jeff George Lays Out Vision

Jeff George, President & Global Head of Alcon, shares his optimism for the ophthalmology sector with attendees at the recent Ophthalmology Innovation Summit in Chicago. George explained where Alcon was putting research ...

Listen

November 11, 2014 By Tom Salemi

Anido Guides Aerie’s Push To Be A “Very Big Player” In Glaucoma

Anido Guides Aerie’s Push To Be A “Very Big Player” In Glaucoma

Vicente Anido, Jr., PhD’s career has taken him through large companies and private start-ups. He’s taken life science companies public on two occasions, and he’s seen nearly every perspective of the ophthalmology ...

Listen

September 29, 2014 By Tom Salemi

Ophthalmology Leaders Speak to Strength of Sector

Ophthalmology Leaders Speak to Strength of Sector

A Wall Street Journal analysis of venture capital commitments showed ophthalmology remained the strongest sector within healthcare. According to the Wall Street Journal, privately held ophthalmology start-ups drew ...

Read More

September 17, 2014 By Tom Salemi

The Role of OUS Clinical Studies

The Role of OUS Clinical Studies

Malvina B. Eydelman, MD give her presentation on some of the newest directions coming out of the FDA for device studies in the US followed by a panel discussion on clinical studies in the US vs. clinical studies ...

Play Video

April 24, 2014

Cross Linking Market Overview

Cross Linking Market Overview

Presenter: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency ...

Play Video

April 24, 2014

Neovista – A Challenging Journey

Neovista – A Challenging Journey

Versant Ventures Managing Director William J. Link PhD talks about the journey of NeoVista through all of its ups and downs. Ultimately Neovista was able to get its CE Mark, but failed to get approved by the FDA due to a ...

Play Video

April 24, 2014

Cross Linking – Panel Discussion

Cross Linking – Panel Discussion

Moderators: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency ...

Play Video

April 24, 2014

  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

STAY UP TO DATE WITH OIS!

Get the latest news, podcasts and videos. Subscribe Today!

Subscribe Today

Keywords

Allergy AMD Biopharma Brand Drugs Cataract Collaboration Cornea Diabetic Macular Edema Diabetic Retinopathy Diagnostics Digital Ophthalmology Drug Delivery Dry Eye EMR/EHR FDA Financing Gene Therapy Glaucoma Implantable Inlays Innovation IOL IPO Lasers M&A Medicare Medtech MIGS Mobile Apps NEI Ocular Oncology Ophthalmologists Ophthalmology Orphan Drugs Pediatrics Presbyopia R&D Refractive Regulation Retina Stem Cells Surgery Surgical Telemedicine Venture Capital

About OIS
Events
News
Videos
OIS Podcast
OIS Index
Contact Us

Call Us: 516-765-9005

GET INVOLVED

Sponsorship Opportunities
Presenting Companies
Companies to Watch
Media & Press
Advertise with OIS
Be Our Podcast Guest

Upcoming Events

OIS@ASRS 2018
OIS@AAO 2018

Connect With Us

  • Facebook
  • Linkedin
  • Twitter
  • YouTube

© 2018 · Ophthalmology Innovation Summit · Powered by Healthegy · Terms & Conditions · Privacy Policy